Solasia Pharma K.K. (4597.T)
JPY 33.0
(0.0%)
JPY 33.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -1.11 Billion JPY | 56.36% |
| 2022 | -2.54 Billion JPY | -2.87% |
| 2021 | -2.47 Billion JPY | 39.98% |
| 2020 | -4.12 Billion JPY | -121.05% |
| 2019 | -1.86 Billion JPY | 22.91% |
| 2018 | -2.42 Billion JPY | -140.4% |
| 2017 | -1 Billion JPY | -112.35% |
| 2016 | -474.43 Million JPY | 26.32% |
| 2015 | -643.88 Million JPY | 4.9% |
| 2014 | -677.03 Million JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | -310 Million JPY | 9.88% |
| 2024 Q2 | -300 Million JPY | 3.23% |
| 2023 Q4 | -344 Million JPY | -3.93% |
| 2023 Q1 | -241 Million JPY | 51.8% |
| 2023 Q2 | -196 Million JPY | 18.67% |
| 2023 Q3 | -331 Million JPY | -68.88% |
| 2023 FY | -1.11 Billion JPY | 56.36% |
| 2022 Q3 | -800 Million JPY | -26.78% |
| 2022 Q1 | -614 Million JPY | -67.3% |
| 2022 FY | -2.54 Billion JPY | -2.87% |
| 2022 Q4 | -500 Million JPY | 37.5% |
| 2022 Q2 | -631 Million JPY | -2.77% |
| 2021 Q3 | -716 Million JPY | 2.98% |
| 2021 FY | -2.47 Billion JPY | 39.98% |
| 2021 Q1 | -656 Million JPY | 70.05% |
| 2021 Q2 | -738 Million JPY | -12.5% |
| 2021 Q4 | -367 Million JPY | 48.74% |
| 2020 Q2 | -740 Million JPY | -39.36% |
| 2020 Q3 | -665 Million JPY | 10.14% |
| 2020 FY | -4.12 Billion JPY | -121.05% |
| 2020 Q1 | -531 Million JPY | -172.31% |
| 2020 Q4 | -2.19 Billion JPY | -229.32% |
| 2019 Q3 | -579 Million JPY | -8.83% |
| 2019 Q1 | -560 Million JPY | 37.01% |
| 2019 FY | -1.86 Billion JPY | 22.91% |
| 2019 Q4 | -195 Million JPY | 66.32% |
| 2019 Q2 | -532 Million JPY | 5.0% |
| 2018 Q4 | -889 Million JPY | -44.08% |
| 2018 Q3 | -617 Million JPY | -3.7% |
| 2018 Q2 | -595 Million JPY | -85.94% |
| 2018 Q1 | -320 Million JPY | 46.32% |
| 2018 FY | -2.42 Billion JPY | -140.4% |
| 2017 Q1 | -241.08 Million JPY | -1385.91% |
| 2017 Q2 | -304.64 Million JPY | -26.36% |
| 2017 Q3 | 134.34 Million JPY | 144.1% |
| 2017 FY | -1 Billion JPY | -112.35% |
| 2017 Q4 | -596.08 Million JPY | -543.71% |
| 2016 Q4 | -16.22 Million JPY | 91.74% |
| 2016 FY | -474.43 Million JPY | 26.32% |
| 2016 Q3 | -196.4 Million JPY | 1.83% |
| 2016 Q2 | -200.05 Million JPY | -223.97% |
| 2016 Q1 | -61.75 Million JPY | 67.13% |
| 2015 Q3 | -231.37 Million JPY | 0.0% |
| 2015 Q4 | -187.86 Million JPY | 18.81% |
| 2015 FY | -643.88 Million JPY | 4.9% |
| 2014 FY | -677.03 Million JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | 134.696% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 100.772% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 99.647% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 100.686% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | 1120.567% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 104.302% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 113.857% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 102.622% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | 259.541% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 107.96% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | 124.456% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | 180.755% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | -517.778% |
| Tsumura & Co. | 16.7 Billion JPY | 106.656% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 109.964% |
| Torii Pharmaceutical Co., Ltd. | 4.11 Billion JPY | 126.997% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 106.876% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | 132.373% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | 114.383% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | 120.894% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 77.278% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | 133.748% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 43.347% |
| MedRx Co., Ltd | -932 Million JPY | -19.313% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | 129.463% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 53.508% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | 114.738% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 108.12% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | -88.727% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 105.383% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | 137.742% |